These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18482026)

  • 1. Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury.
    Lee JH; Park SY; Shin HK; Kim CD; Lee WS; Hong KW
    CNS Neurosci Ther; 2008; 14(2):143-52. PubMed ID: 18482026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation].
    Ishiguro M; Hara H
    Yakugaku Zasshi; 2011 Apr; 131(4):513-21. PubMed ID: 21467790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol: therapeutic potential against focal cerebral ischemic damage.
    Hong KW; Lee JH; Kima KY; Park SY; Lee WS
    Curr Pharm Des; 2006; 12(5):565-73. PubMed ID: 16472148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake.
    Liu Y; Shakur Y; Yoshitake M; Kambayashi Ji J
    Cardiovasc Drug Rev; 2001; 19(4):369-86. PubMed ID: 11830753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats.
    Choi JM; Shin HK; Kim KY; Lee JH; Hong KW
    J Pharmacol Exp Ther; 2002 Mar; 300(3):787-93. PubMed ID: 11861782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol attenuates ischemic brain injury and enhances neurogenesis in the subventricular zone of adult mice after transient focal cerebral ischemia.
    Tanaka Y; Tanaka R; Liu M; Hattori N; Urabe T
    Neuroscience; 2010 Dec; 171(4):1367-76. PubMed ID: 20933581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat.
    Lee JH; Park SY; Shin HK; Kim CD; Lee WS; Hong KW
    Brain Res; 2007 Jun; 1152():182-90. PubMed ID: 17433265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats.
    Lee JH; Kim KY; Lee YK; Park SY; Kim CD; Lee WS; Rhim BY; Hong KW
    J Pharmacol Exp Ther; 2004 Mar; 308(3):896-903. PubMed ID: 14634032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion.
    Watanabe T; Zhang N; Liu M; Tanaka R; Mizuno Y; Urabe T
    Stroke; 2006 Jun; 37(6):1539-45. PubMed ID: 16645134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke.
    Kim YR; Kim HN; Hong KW; Shin HK; Choi BT
    Psychopharmacology (Berl); 2016 Mar; 233(6):1055-66. PubMed ID: 26686236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats.
    Park SY; Lee JH; Kim CD; Rhim BY; Hong KW; Lee WS
    Brain Res; 2007 Jul; 1157():112-20. PubMed ID: 17521620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat.
    Toda Y; Katsura K; Saito M; Inaba T; Sakurazawa M; Katayama Y
    Neurol Res; 2014 Nov; 36(11):1011-9. PubMed ID: 24836463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage.
    Nonaka Y; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neurosci Lett; 2009 Mar; 452(2):156-61. PubMed ID: 19383431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries.
    Ye YL; Shi WZ; Zhang WP; Wang ML; Zhou Y; Fang SH; Liu LY; Zhang Q; Yu YP; Wei EQ
    Eur J Pharmacol; 2007 Feb; 557(1):23-31. PubMed ID: 17161838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model.
    Kasahara Y; Nakagomi T; Matsuyama T; Stern D; Taguchi A
    Stroke; 2012 Feb; 43(2):499-506. PubMed ID: 22033992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol: a review of its use in intermittent claudication.
    Chapman TM; Goa KL
    Am J Cardiovasc Drugs; 2003; 3(2):117-38. PubMed ID: 14727939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
    Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH
    Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol attenuates gray and white matter damage in a rodent model of focal cerebral ischemia.
    Honda F; Imai H; Ishikawa M; Kubota C; Shimizu T; Fukunaga M; Saito N
    Stroke; 2006 Jan; 37(1):223-8. PubMed ID: 16339464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
    Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS
    Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study.
    Sakurai H; Hanyu H; Sato T; Kume K; Hirao K; Kanetaka H; Iwamoto T
    Geriatr Gerontol Int; 2013 Jan; 13(1):90-7. PubMed ID: 22672107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.